“Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics”, Valensi, vol. 10, no. 1, pp. 27–44, May 2024, doi: 10.15408/jkv.v10i1.34258.